Novo Nordisk A/S

Key Statistics

Recent News

• 3 Ridiculously Cheap Healthcare Stocks to Buy in June 24/7 Wall St.

  Healthcare has spent 2026 on the sidelines while the rest of the market does the heavy lifting. The Health Care Select Sector SPDR Fund (NYSEARCA:XLV) is down around 1% year to date even after a 6% on

• Novo Nordisk (NVO) Reports Positive Phase 3 Reimagine Trial Results Insider Monkey

  Novo Nordisk A/S (NYSE:NVO) is one of the 7 Best Longevity Stocks to Buy Now. On June 7, 2026, Novo Nordisk A/S (NYSE:NVO) presented Phase 3 results from its Reimagine 1-3 trials, which showed signifi

• These 3 Quality Stocks Will Make You Want to LEAP on Their Calls Barchart

  Thursday’s unusual options activity had plenty to choose from. However, it was the LEAPS that were really worth considering for bullish investors. Of the 28 calls over 365 days, these three quality st

• Pfizer's New Weight-Loss Data Just Gave Eli Lilly and Novo Nordisk Investors Something to Worry About Motley Fool

  The pharmaceutical company's flagship anti-obesity drug continues to bolster its efficacy and tolerability arguments.

• UK gives Wegovy GLP-1 pill first European approval Just Drinks

  The authorisation by the UK's Medicines and Healthcare products Regulatory Agency makes the country the third to licence the medication after the US and the UAE.

• Novo Nordisk Stock Up as UK Wegovy Pill Nod Eclipses Security Breach Zacks

  NVO stock gains 3% as the United Kingdom becomes Europe's first country to approve the daily GLP-1 Wegovy weight-loss pill, overshadowing an IT security breach.

• Update: Market Chatter: Some US Employers Plan to Drop GLP-1 Coverage for Obesity in 2027 MT Newswires

  (Updates with Eli Lilly's response to a request for comment from MT Newswires.) Some employers in

• Novo Nordisk comeback stirs as Wegovy pill wins UK approval Pharmaceutical Technology

  There are already lengthy patient waitlists for the medication on digital health platforms.